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ABSTRACT 
 
Computer Simulation and Comparison of Proton and Carbon Ion Treatment of Tumor 
Cells Using Particle and Heavy Ion Transport Code System.  (December 2010) 
Keel Brandon Curtis, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Stephen Guetersloh 
 
 Charged particle beams are an increasingly common method of cancer 
treatment.  Because of their Bragg peak dose distribution, protons are an effective way 
to deliver a dose to the tumor, while minimizing the dose to surrounding tissue.  
Charged particles with greater mass and higher charge than protons have an even 
sharper Bragg peak and a higher Relative Biological Effectiveness (RBE), allowing a 
greater dose to be delivered to the tumor and sparing healthy tissue. Since carbon ions 
are being implemented for treatment in Europe and Japan, this study will focus on 
carbon as the heavier ion of choice.  Comparisons are drawn between moderated and 
unmoderated protons and carbon ions, all of which have a penetration depth of 10 cm 
in tissue.  Scattering off the beam line, dose delivered in front of and behind the tumor, 
and overall dose mapping are examined, along with fragmentation of the carbon ions.
 It was found that fragmentation of the carbon ion beam introduced serious 
problems in terms of controlling the dose distribution.  The dose to areas behind the 
tumor was significantly higher for carbon ions versus proton beams.  For both protons 
and carbon ions, the use of a moderator increased the scattering off of the beam line, 
and slightly increased the dose behind the tumor.  For carbon ions, the use of a 
moderator increased the degree of fragmentation throughout the beam path. 
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1. INTRODUCTION 
Radiation is one of the major forms of treatment for tumors available today.  
Radiation is used in curing 23% of all cancers, either alone or in combination with 
chemotherapy or surgery (IAEA/ICRU 2008).  The oldest type of radiation therapy is 
simple irradiation of a tumor with x-rays, first used more than 100 years ago (Early and 
Landa 1995).  By passing x-radiation through the tumor, doctors hope to deposit 
enough energy within to kill cells, halting or reversing the tumor’s growth.  The 
deposition of energy by radiation is called a dose, and is typically given in Gray (Gy); 1 
Gy is 1 joule per kilogram.  However, two notable properties of x-rays are their 
tendency to scatter, and their exponential attenuation.  Because they are effectively 
weightless, x-ray photons can scatter at large angles from the beam easily.  This can 
lead to dose being delivered far away from the target.  X-rays attenuate exponentially 
because their interactions with target atoms are random.  The interaction rate is tied to 
the number of photons present.  As they travel through a material, photons interact 
and lose energy, and are eventually absorbed.  Thus, the number of photons, as well as 
the dose they deliver, decreases exponentially with depth.  Both of these 
characteristics lead to dose and damage within healthy tissue, which limits the 
maximum dose that can be safely delivered to a tumor.  The more dose that can be 
delivered to a tumor, the greater the likelihood of controlling the tumor, stopping its 
growth or even shrinking it.  Any treatment that can deliver a greater portion of dose to 
the tumor instead of healthy tissue is desirable.   
In 1946 Robert Wilson proposed using protons for tumor treatment. (Schulz-
Ertner and Tsujii 2007)  Unlike uncharged photons, positively charged protons primarily 
slow down through many Coulomb interactions with the positive nuclei and negative  
electrons comprising a target material. (Attix 2004) Each interaction transfers a small 
amount of energy from the incident particle to the medium through which it is  
____________ 
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travelling.  This is known as a “soft” collision.  Occasionally, the incident particle will 
come closer to a particular atom and interact with an orbiting electron, a “hard” 
collision, transferring enough energy to eject the electron from its shell as a delta ray.  
These delta rays are low energy, and appear as short-ranged spurs from the main 
particle track.  Together, these two types of interaction sum to give the total stopping 
power, the differential energy lost per unit distance travelled through a material.  
Stopping power is closely related to Linear Energy Transfer (LET), the amount of energy 
transferred to the medium being traversed per unit length.  Stopping power is given by 
eqn (1): 
        
     
         
    
         
    
                                                          
 
As shown above, stopping power is often given as Mass Stopping 
Power,      , in an effort to normalize materials of different densities, effectively 
setting them to the same mass.  By inserting approximations for the hard and soft 
terms, and combining constants, such as electron radius, mass, the speed of light, and 
others, we can reach a form of eqn (1) more useful for computation, as presented in 
eqn (2): 
        
     
       
   
   
            
  
    
                              
  
where  
Z=atomic number of the target material 
z=atomic number of the particle 
A=atomic mass of the target material 
β=velocity of the particle as a fraction of the speed of light 
I=mean excitation potential of the medium, in eV. 
The atomic composition of the material is important in this equation.  The Z/A 
factor for the target material is directly proportional to the number of electrons per 
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unit mass.  Mass stopping power increases with more electrons per unit mass.  Z/A is 
unity for hydrogen, and is less than 0.5 for other elements, decreasing slowly as Z 
increases. The mean excitation potential is a mean value of all the ionization and 
excitation potentials of a particular atom or compound. It is given in electron volts (eV), 
the amount of energy gained by an electron as it crosses a 1 volt potential.  The 
conversion factor for is 1 eV = 1.602x10-19 J; units of keV (1,000 eV) and MeV (1,000,000 
eV) are also commonly used.  The factor -ln I also decreases mass stopping power 
slowly with increasing Z.  Because the materials in this experiment are unchanging, 
these factors will remain constant. 
The projectile particle’s charge and velocity are also factors.  Velocity is given as 
the fraction of the speed of light that the particle is traveling, β = v/c.  Thus, β is 
unitless.  As β is in the denominator, stopping power decreases with increasing β, so 
higher velocity particles have lower stopping power.  Stopping power increases with 
the square of charge or atomic number (z).  For example, an alpha particle, z=2, has a 
stopping power 4 times greater than a single proton, z=1, at the same velocity.   
Stopping power does not depend directly on the particle’s mass.  However, given equal 
total energies, a heavier particle has a lower velocity than a lighter particle.  Discussing 
particle energies on a per-nucleon basis equates energy to equal velocities and we can 
more easily compare them. 
Because of these differences in the way they lose energy, protons and heavier 
ions behave very differently from photons as they travel through materials.  At the end 
of their tracks, the stopping power of protons increases dramatically.  This leads to a 
phenomenon known as the Bragg peak.  When dealing with particles more massive and 
highly charged than protons, such as helium nuclei or carbon nuclei, the increase in LET 
at the end of the track is even more pronounced.  The differing energy loss profiles of 
photons, protons, and carbon ions are shown in Fig. 1. 
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Fig. 1.  A Typical Bragg Peak for Protons and Carbon.  The proton and photon curves are 
normalized to show the same dose at 145 mm.  The carbon ion curve is normalized to give the 
same entrance dose as protons.  Photons deliver more dose to areas in front of the target than 
the target itself.  Carbon ions can deliver 50% more dose at the target than protons with an 
equal entrance dose. (Schulz-Ertner and Tsujii 2007)1 
 
As shown in Fig. 1, photons have a high entrance dose, peaking at 2-3 cm depth.  
The dose falls off exponentially afterwards, reaching about 60% of the maximum at the 
target depth.  The maximum usable dose of radiation for cancer treatment is limited by 
the dose to healthy tissue.  One way to control dose to healthy tissue is to use multiple 
x-ray beams from different angles, also known as ports.  The x-ray beams are aimed so 
that the tumor is the target for each one, but each beam travels through different 
sections of healthy tissue.  For example, instead of using a single beam, two beam ports 
                                                          
1
 Reprinted with permission. © 2008 American Society of Clinical Oncology.  All rights reserved. 
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each delivering half of the dose would be used.  The dose to the tumor remains the 
same; the dose to healthy tissue is reduced by half.   
Fig. 1 also shows the dose distributions for charged particles, in this case 
protons and 12C ions.  At the end of their range both exhibit the steep increase in 
energy deposition known as a Bragg peak.  For equal doses at 140 mm depth, protons 
give a much lower entrance dose than photons.  Using carbon ions with the same 
entrance dose as protons, the dose at 140 mm is increased by 50% and the peak is 
narrower.   Fig. 1 also shows that the charged particle dose deposition drops off very 
quickly as the ion stops completely after the peak, unlike a photon beam that continues 
to travel and deliver dose through the medium.   
Though they show favorable dose deposition profiles, heavy ions such as carbon 
can also fragment, which is not possible for either photons or protons.  Fragmentation 
is the breakup of the initial particle breaks into smaller particles.  Carbon, with a Z of 6, 
could fragment into two particles with Z=2 (helium) and Z=4 (beryllium), for example.  
This presents complications for ion use in therapy.  If the ions did not fragment, their 
energy deposition would drop sharply to zero at the end of their range much like 
protons, as shown in Fig. 1.  However, lower-Z secondary fragments have longer ranges 
than the primary particles for a given velocity.  These fragments are then able to deliver 
dose beyond the tumor.  The straggling effect of fragmentation increases with 
increasing Z. (Schardt et al. 1996) 
In addition to fragments, charged particles, (including protons) create delta rays.  
As they travel, charged particles transfer energy to atoms of the target material.  Much 
of this energy is transferred to electrons.  Electrons that receive enough energy can 
leave their parent atom as a delta ray.  The more energy imparted to a delta ray, the 
longer its range.  Therefore carbon, at the same energy per nucleon as a proton, has 
the potential to produce many more delta rays carrying energy away from the intended 
path.  Delta rays can also create photons in their own interactions with the target 
material.  These photons also carry energy away from the charged particle track. 
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1.1 Radiation Biology 
When energy is transferred to living cells, harmful effects may occur.  The most 
harmful effect, to healthy tissue and tumors, is damage to DNA (Hall and Giaccia 2006).  
All cells have repair mechanisms to detect and fix damage done by radiation and other 
insults. (Hall and Giaccia 2006) However if these mechanisms make errors, or are 
overwhelmed by severe and widespread damage, the changes in DNA can be 
permanent.  These mutations can impair the cell’s ability to grow and reproduce, or 
even kill it outright.  Unrepaired DNA can also be passed on to daughter cells, creating a 
new generation of mutant cells.  All of these effects are undesirable in healthy tissue, 
but are the key to shrinking and killing tumors.   
Compared to protons, heavy ions (Z>2) have an increased relative biological 
effectiveness (RBE) when causing changes in cells (IAEA/ICRU 2008).  RBE is a 
comparison of two different types of radiation, typically high and low LET.  To measure 
RBE, two types of radiation are used to achieve the same endpoint, 50% cell death for 
example, with x-ray or gamma exposures being the reference radiation.  This will occur 
at a different dose for each type.  Then the low-LET dose is divided by the high-LET 
dose, and this gives a ratio.  This ratio is the RBE of the high-LET radiation compared to 
the low-LET.   In this report, the RBE endpoint is tumor cell inactivation, unless 
otherwise mentioned.  
Dose multiplied by quality factor is effective dose.  Quality factor is closely 
related to and often drawn from RBE.  This allows easier comparison of different doses 
that should have similar biological effects.  The unit for effective dose is the Sievert (Sv) 
which is equal to 1 Gy at a quality factor of 1. 
 Effective cancer control requires that radiation does enough damage to DNA to 
cause the cancer cell to die or stop reproducing.  Because DNA is comprised of two 
strands, it can be damaged by either single or double strand breaks (SSB, DSB 
respectively), among other types of damage.  A DSB is a complete cut across a segment 
of DNA, and is harder for a cell to repair than other types of damage.  Photons cause 
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damage in a very spread out pattern. High-LET radiation is more likely to cause complex 
damage because of nuclear interactions and the dense delta ray cloud surrounding the 
track. (Durante and Cucinotta 2008)  Complex damage is when multiple DSBs, SSBs or 
other damage occur in a small section of DNA.  Complex damage is extremely hard to 
repair properly.   
Cancer cells often have poorly-functioning repair mechanisms compared to 
healthy cells.  (Rusin et al. 2009)  This leads to a program of dose fractionation.  Instead 
of one large dose, a cancer patient is given smaller daily doses over the course of a few 
weeks.  Cancer cells often have a poor system to halt cell growth and division compared 
to healthy cells.  Fractionation allows healthy cells to halt cell growth and repair, while 
cancer cells are more likely to try and grow with damaged DNA.  These cells are more 
likely to experience cell death or an inability to continue growth and division. (Pawlik 
and Keyomarsi 2004) 
 
1.2 Carbon Ions 
As shown in Fig. 1 the Bragg peak for carbon ions is even sharper and narrower 
than that of protons.  In addition, carbon ions have a higher RBE at the end of their 
tracks.  While protons have an RBE of about 1.1, values for carbon go as high as 4. 
(Schulz-Ertner and Tsujii 2007)  Additionally, being a much more massive nucleus, 
carbon scatters much less.  Many researchers have taken these as reasons to believe 
that heavy ions are even more precise and effective than protons for beam therapy.  
While higher-Z particles offer even higher LET values at the end of their tracks, they 
also suffer from a greater degree of fragmentation, increasing the relative dose beyond 
the Bragg peak.  Also, at higher LET values, the RBE begins to decrease, as overkill 
effects come into play.  Overkill is when the radiation is so damaging that it has a 100% 
kill rate for cells it enters.  Further increasing the energy deposition does not do any 
more damage and the excess energy is ‘wasted’.   Thus, carbon and oxygen beams have 
been focused on as possible therapy beams though debate continues as to whether the 
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benefits of heavier nuclei outweigh the problems that fragmentation poses. (Schardt et 
al. 1996) 
Furthermore, the cost of accelerators to produce heavy ions is higher than the 
cost of a proton accelerator.   Because of the very narrow Bragg peak, imaging and 
delivery systems also need to be more precise for heavy ion treatment.  Thus, the 
overall cost is significantly higher; this has limited their use in research studies and 
patient treatment.  However, some heavy ion trials in Germany and Japan have been 
conducted using carbon. The results have been promising, with a high degree of local 
control, and minimal side effects. (Shulz-Ertner 2003, Imai et al. 2004 ) The expected 
cost for a typical proton therapy center was about $125 million in 2009. (Huff 2007)  
The expected cost for a carbon therapy center is between $200 and $300 million in 
2009, though this may be reduced greatly for subsequent centers. (Zamosky 2009, 
Yamada 2007) As of March 2009, only 5342 patients worldwide have been treated with 
carbon therapy, compared to over 60,000 with protons.  There are only 3 facilities, 2 in 
Japan, 1 in Germany, that currently offer carbon ion treatments, while 26 facilities, 
including some in the U.S., offer treatment with protons.  Carbon ions need more 
biological studies, clinical trials and availability if their usefulness and cost-effectiveness 
are to be proven.  
 
1.3 Simulation 
 In order to investigate the behavior of both protons and carbon ions the 
program Particle and Heavy-Ion Transport code System (PHITS) was used.  PHITS was 
developed in collaboration by the Research Organization for Information Science and 
Technology (RIST), Tohoku University, and Japan Atomic Energy Institute. (Niita 2006)   
The code takes the incident particle’s energy, direction, and type, and uses 
known probabilities to simulate its interaction with matter.  PHITS is similar in design to 
MCNP (Monte Carlo N-Particle code), a program that focuses primarily on neutral 
particles such as photons and neutrons, but PHITS simulates charged particle 
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interactions such as energy deposition, fragmentation, and ionization and excitation of 
target atoms.  To run PHITS, an input file is created with several sections.  The PHITS 
program parses this input file, runs the simulation within, and creates several output 
files based on what is called for in the input file. 
 The first section of the input file contains global variables.  This section contains 
references to data libraries to be used and defines the number of particles to be ‘run’.  
PHITS creates particles one at a time, simulating interactions based on the probability 
of those interactions occurring given the particle’s energy and other factors.  It follows 
the primary particle and the secondary particles created by the primary, until the 
particles fall below their energy cutoff value.  These cutoff values are also defined in 
the first section of the input file.  By increasing the number of particles and decreasing 
the cutoff values, so they are followed farther, the user can increase the precision of 
the PHITS output data.  However, this also increases the computing time required.  It is 
necessary to strike a balance between accurate data and reasonable computing time. 
 The next section is a beam definition.  Here the type of particle and energy are 
defined.  The shape and size of the beam are also set, as well as its direction.  The 
following two sections are surfaces and cells.  Surfaces are simple geometric shapes, 
such as planes, cylinders, and spheres.  These surfaces are combined to create cells.  
Cells must be completely closed, and are given a material definition.  The user can 
create spheres of water, cylinders of air, rectangular boxes of soft tissue, or more 
complex creations. 
 The last sections are called tallies.  These extract data from the simulation that 
is being run and create output files.  Tallies can tell how many particles entered a 
certain cell, how much energy they deposited, and more.  Correctly using tallies is 
crucial to getting useful data out of PHITS. 
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2. EXPERIMENTAL SETUP 
 In order to test the effectiveness of carbon ions for treatment, they were 
compared to proton beams with the same range in tissue.  The simulation environment 
is a simple tissue-equivalent plastic cylinder, 10cm in radius.  Tissue equivalence means 
that radiation entering the material is expected to interact and slow down in a very 
similar fashion to radiation entering human soft tissue.  The atomic composition of the 
tissue substitute used is given in Table 1. 
 
Table 1. Atomic Composition of A-150 Plastic. (Smathers et al. 1977)  
Element Abundance 
Carbon 76.8% 
Hydrogen 10.2% 
Oxygen 5.9% 
Nitrogen 3.6% 
Calcium 1.8% 
Fluorine 1.7% 
 
At the center of the tissue cylinder is a 1 cm cube, representing the tumor 
target.  A sequential series of small boxes, composed of the same plastic, extends 
beyond the tumor cell.  These are used in a tally to score dose to regions behind the 
tumor.  A similar line of boxes extends perpendicular to the beam line.  These are also 
used for dose deposition radially from the tumor.  The setup is shown in Fig. 2.  
11 
 
 
Fig. 2. Experimental Setup.  The blue circle is the A-150 plastic cylinder.  The pink rectangle 
shows the polyethylene moderator used in some of the simulations.  The green line represents 
the beam. The L shape of boxes is a series of small cells for the purpose of taking tallies along 
the beam line behind and perpendicular to the beam line.   
 
Many ion treatment protocols provide ions of the desired energy and range by 
passing a high-energy ion beam through a moderator before it hits the tissue. By 
choosing the proper thickness, the reduced-energy ions leaving the moderator then 
have the proper range to reach the target area.  A more advanced technique is to use 
the accelerator to vary the initial energy of the beam, releasing it when it has reached 
the desired energy.  These two techniques are represented by simulations run with and 
without a moderator.  The moderated simulations used a 6.5 cm block of polyethylene 
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(CH2) between the beam and the tissue.  The beams being compared are given in Table 
2. 
 
Table 2.  Beam Types and Initial Energies. 
 
 
 
 
 
 
 
A total of 4 different beams were run, 2 different particle types, and a 
moderated and unmoderated run for each particle type.  A moderated 290 MeV/u 
carbon ion beam is typical for use in therapy.  After the energy is degraded with a 6.5 
cm moderator, it has a range of 10 cm in tissue.  The other beams are given initial 
energies such that their range will also be 10 cm in tissue. The unmoderated beams 
represent the case of using the accelerator itself to select for the correct energy, and 
therefore range. They have a lower initial energy but do not pass through a moderator, 
giving them the same range as the moderated beams.   In all cases the beam was a 
0.1cm radius pencil beam, starting 7 cm away from the surface of the tissue cylinder.  
The diameter of the beam was kept small even for the case of the moderated 
treatments, which are usually the size of the tumor to be treated, so an assessment of 
lateral divergence could be compared. To reduce statistical uncertainty while 
preserving a reasonable run time, the number of particles simulated was 400,000.  The 
runtime for each simulation was around 16 hours, with cutoff energies of 0.1 keV for 
most particles. 
 
  
Particle Type and Energy Moderator Presence 
Carbon 290 MeV/u Moderated 
Carbon 219 MeV/u Unmoderated 
Proton 155 MeV Moderated 
Proton 117 MeV Unmoderated 
13 
 
3. RESULTS 
 For each experimental setup, a 2d color plot of energy deposition within the 
tissue cylinder was created using a 2-dimensional output that maps magnitude to a 
color scale. Because this material has unit density (1 gm/cm3) this means energy 
deposition is directly proportional to dose per particle.  If a standard number of 
particles were picked, multiplying the energy deposition per particle by the number of 
particles would give a dose map.  Figs. 3-6 are essentially blown-up images of the blue 
circle in Fig. 2. 
In Fig. 3, the carbon beam stops at (0,0), but the orange shadow shows 
fragments continuing to travel through the tissue.  The beam is thicker than the 
unmoderated carbon beam, shown in Fig. 4, but narrow compared to the proton 
beams, shown in Figs. 5-6.  Compared to the other beams, moderated carbon also has 
the highest overall dose to the entire area. 
By eliminating the moderator, the dose away from the beam line is noticeably 
decreased in Fig. 4.  Individual tracks can even be seen near the front of the tissue 
cylinder.  The dose is similar along the line of the treatment beam, but drops off rapidly 
with distance radially away from the line.  The red line showing the highest dose 
deposition due to carbon ions or fragments, instead of delta rays, is narrower than the 
moderated beam.  The dose behind the tumor is also slightly decreased, but still 
significant. 
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Fig. 3.  Moderated Carbon 2d Dose Plot.  The tumor target is located in the center of this plot, 
at (0,0).  Energy deposition is in a logarithmic color scale.  The beam path is visible as a red line 
on the left half of the figure.  The experimental tumor volume is the small box in the center.  
Heat is a PHITS term for energy deposited in a region per source particle emitted. Because the 
target material is unit density, in Figs. 3-6, heat is directly proportional to dose. 
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Fig. 4.  Unmoderated Carbon 2d Dose Plot. This carbon beam does not pass through a 
moderator so it does not begin slowing down and scattering until it enters the tissue cylinder. 
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Fig. 5.  Moderated Proton 2d Dose Plot.  This proton beam is passed through a 6.5 cm 
moderator before entering the tissue cylinder.  Because protons cannot fragment, the energy 
deposition behind the tumor is practically zero. 
 
 Only the sporadic tracks of delta particles and photons are visible past the 
tumor.  However, the dose to areas in front of the tumor is greater than in Figs. 3 and 4.  
The red area of greatest dose is much thicker for proton therapy, especially at the end 
near the tumor.  The orange area of next highest dose around the beam line is also 
thicker. Scattering has increased the dose to all areas in a wide path in front of the 
tumor. 
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Fig. 6.  Unmoderated Proton 2d Dose Plot.  This proton beam does not pass through a 
moderator.  Scattering is greatly reduced as a result. 
 
 When the moderator is eliminated, the dose conforms more tightly to the beam 
path.  The beam line is thinner, as is the orange area around it.  Overall the red line of 
the beam is comparable to the moderated carbon beam shown in Fig. 3.  Scattering far 
off the beam line is decreased greatly.  Again the dose is almost zero past the target, 
showing only delta particles and photons. 
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 Another set of tallies was used to compare doses in the sequential 1cm3 cubes 
behind the tumor target.  This shows how the dose falls off beyond the range of the 
primary particles.  The PHITS tallies give results in MeV/source particle.  This means 
that for every particle created, that much energy was deposited in the region of 
interest.    Dose is energy per unit mass and since the mass of the region is known, 
finding the energy needed to achieve a certain dose is simple: 
                  
      
        
                                                                           
 
  By setting the desired dose to the tumor region to 5 Gy, the number of source 
particles needed for that dose can be calculated using eqn (3).  5 Gy was chosen as a 
median dose, many studies showed both lower and higher doses delivered to tumors. 
(Souhami et al. 1991, Krishnanan et al. 2005)  This same number of particles was then 
used for the regions behind the tumor, showing the dose delivered behind the tumor 
for a 5 Gy dose directly to the tumor.  This allowed easier comparisons between proton 
and carbon ion beams, since carbon beams deposit more energy per particle.  The 
initial runs with 400,000 particles were scaled up to correct for the proper fluence to 
deliver a 5 Gy dose.  The number of particles required to give a dose of 5 Gy to the 
tumor for each case are given in Table 3.  
 
Table 3.  Number of Particles Required to Reach a 5 Gy Tumor Dose. 
Trial Number of Particles 
Carbon with Moderator 1.01x109 
Carbon without Moderator 2.51x108 
Proton with Moderator 5.19x109 
Proton without Moderator 4.46x109 
 
Fig. 7 shows the results of multiplying the dose/particle number by the number 
of particles needed for 5 Gy. 
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Fig. 7.  Dose Delivered Behind the Tumor.  0 is the tumor volume, while 1-5 are cells 1-5cm 
behind the tumor along the beam line. 
 
 The dose from both proton beams drop very quickly behind the tumor.  After 1 
cm, the dose is decreased by 5 orders of magnitude from the tumor.  The only dose at 
that point is due to delta rays and photons created near the end of the protons’ tracks.  
The carbon ion drops are not nearly as a steep.  At 3 cm behind the tumor, the 
moderated carbon dose is still 0.457 Gy.  The unmoderated dose at 3 cm is 0.08 Gy. 
 The same analysis was done for regions beside the tumor, perpendicular to the 
beam line.  Dose was normalized to 5 Gy, and regions from 1-5 cm away from the 
tumor were scored.  The results are in Fig. 8. 
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Fig. 8.  Dose Delivered Perpendicular to the Tumor.  Again, 0 is the tumor.  1-5 are regions 1-5 
cm away laterally. 
 
 In this case, the moderated schemes have higher doses than the unmoderated 
schemes, but the dose is comparable for all beams.   The proton schemes decrease 
more quickly than the carbon schemes at the 4-5 cm range. 
 For the carbon schemes only, fragmentation was also tallied.  A tally was 
created that counted the number and type of particle at various points along the beam 
line.  It was measured as the fraction of particles per source particle. Thus for carbon, it 
is a simple percentage remaining.   For other particles, it is a measure of how many are 
created per initial carbon ion.  A value of 0.5 for protons means that for every 2 carbon 
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ions in the initial beam, 1 proton was present at that point on the z axis.  Thus, the 
higher the number, the more prevalent that particle was at that point on the axis.  Fig. 
9 shows the fragmentation of the moderated carbon beam. 
 In Fig. 9 carbon starts at about 80% of the initial fluence incident on the 
moderator, drops gradually to approximately 40%, and then falls off completely as it 
stops in the tumor.  It is being replaced by its fragments, mostly alpha particles, 
followed by neutrons and protons.  After all the carbon is stopped, new fragments from 
carbon are no longer being created (although large fragments such as alpha particles 
could fragment again), and the population of fragments begins to fall as they are 
stopped behind the target.  Fig. 10 shows the same tally for an unmoderated carbon 
beam. 
In Fig. 10, the beam begins as pure carbon.  The population of fragments rises 
rapidly, however.  At the end of its range, the beam is approximately 50% carbon 
remaining.  The primary fragments are alphas, neutrons, and protons once again.  
Alpha particles are produced more slowly initially, but peak higher than protons and 
neutrons.  All fragments begin to decrease beyond the target. 
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Fig. 9.  Fragmentation of the Moderated Carbon Beam.  F-curr is forward current.  Forward 
current is the number of particles passing through along the forward z direction, divided by the 
area.   
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Fig. 10.  Fragmentation of the Unmoderated Carbon Beam.  Notice that the various fragments 
all begin at 0, unlike Fig. 9. 
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4. CONCLUSIONS 
 Fragmentation paints a very different picture of carbon ion beams than a simple 
Bragg peak analysis does.  A Bragg peak seems to show that carbon ions deliver dose 
very precisely to a tumor, sparing surrounding tisssue.  And indeed, the carbon ions 
themselves do stop precisely where they are intended to.  However, half or more of 
them have been fragmented into smaller particles by the time they reach the target.  
These fragments have a range of energies and wider Bragg peaks.  The neutron 
fragments are not charged particles, and deposit their energy over a wide area.  These 
smaller particles are also more prone to scattering off of the beam line. 
 Carbon ions show a tighter beam at the treatment site than protons.  They are 
less likely to scatter off at a large angle and deliver dose to healthy tissue off of the 
beam line.  However, the dose to regions behind the tumor is much greater from a 
carbon beam.  This may be the deciding factor in choosing carbon or proton beams.  
The dose to the first centimeter behind the tumor is more than 350 times greater 
(0.911 Gy for carbon, 0.00257 Gy for proton) for carbon compared to protons in the 
moderated setup.  For the 2-5cm regions, and the unmoderated regimes, the 
difference is much greater.   
 For dose beside the tumor, the key factor was not particle type, but the 
presence or absence of a moderator.  Both unmoderated beams delivered lower doses 
to the tissue laterally away from the beam line.  However, the difference wasn’t as 
large as those in the behind-tumor region.  The proton beams also had lower doses at 
the farthest points, because the range of the protons was too short to reach those 
areas. 
 The fragmentation of carbon ions was decreased with the unmoderated beam.  
A significant degree of fragmentation occurred in the moderator itself, increasing the 
fragmentation of the beam at the tumor site. The dose from the umoderated beam was 
only one fifth of the moderated beam dose for all 5 regions behind the tumor.  The 
unmoderated beam also tended to have less scattering;  the dose to areas off the beam 
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line was significantly reduced.  This strongly supports selcting beam energy in the 
accelerator instead of passing it through a physical moderator as a way of controlling 
the initial energy. 
It is important to note that with the increased RBE of carbon within its Bragg 
peak, a lower dose could be used to deliver the same dose equivalent.  If carbon’s RBE 
compared to protons is 4, the dose could be lowered by a factor of 4.  This would 
decrease the the dose behind the tumor due to fragments.  The dose at 1cm behind 
was 350 times greater for carbon than it was for protons.  A reduction by a factor of 4 
still leaves a dose 75 times greater, at 0.23 Gy  However, it also decreases entrance 
dose near the surface of the tissue by a factor of 4.  Though complex, it would be 
worthwhile  to compare the dose equivalents to healthy tissue of carbon and protons 
for a 5 Sv dose equivalent to the tumor.  It may be that carbon offers an advantage in 
that sense.  Or perhaps it’s the case that carbon becomes better for sparing shallow 
tissue, but protons are better for sparing deep tissue.  This could be a future line of 
inquiry. 
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 APPENDIX  
PHITS CODE FOR MODERATED CARBON RUN 
 
[ T i t l e ] 
tumor stack 
 
[ P a r a m e t e r s ] 
 icntl   = 0 
 maxcas  = 10000 
 maxbch  = 100 
 emin(1) = 0.0001 $ cut-off energy for proton (MeV) 
 emin(2) = 0.0001  $ cut-off energy for neutron (MeV) 
 emin(12) = 0.0001  $ cut-off energy for electron (MeV) 
 emin(13) = 0.0001  $ cut-off energy for positron (MeV) 
 emin(14) = 0.0001  $ cut-off energy for photon (MeV) 
 emin(15) = 0.0001  $ cut-off energy for deuteron (MeV/n) 
 emin(16) = 0.0001  $ cut-off energy for triton (MeV/n) 
 emin(17) = 0.0001  $ cut-off energy for 3He (MeV/n) 
 emin(18) = 0.0001  $ cut-off energy for alpha (MeV/n) 
 emin(19) = 0.0001  $ cut-off energy for neucleus (MeV/n) 
$ dmax(1) = 20.0  $ nuclear data max energy for proton (MeV) 
$ dmax(2) = 20.0  $ nuclear data max energy for neutron (MeV) 
$ dmax(12) = 1000.0  $ nuclear data max energy for electon (MeV) 
$ dmax(13) = 1000.0       $ nuclear data max energy for positron (MeV) 
$ dmax(14) = 1000.0  $ nuclear data max energy for photon (MeV) 
 esmin = 0.00001  $ minimum energy for range calculation (MeV) 
 igamma = 1   $ 1: to use the gamma decay option 
 itall = 1   $ 1: to output tally evry batch 
$ iggcm = 1   $ 1: to output the GG warning echo back 
$ ipara = 1   $ 1: to output all parameter 
$ igchk = 1   $ 1: to check geometry 
 file(6) = PHITS.out  $ file name of output summary 
 $ file(7) = D:\PHITS2\PHITS213\library\mcnpxdata\xsdir $ file name of nuclear data 
  file(14)= C:\Users\Keel\Desktop\PHITS216\data\trxcrd.dat $ file name of gamma decay data 
 ides = 0   $ 0: photon produces electron 
 dircha = 1   $ 1: for windows 
$ irskip = 273900  $ for debug 
$ rseed = 102645264135097   $ for debag 
 nedisp = 1   $ energy straggling option 
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 nspred = 1   $ angular straggling option 
 nlost = 200  $ max number of lost particles 
 emcnf = 20.0  $ threshold of neutron capture 
$ set:  M[ 27 ] rho[ 2.7 ] d[ 0.6 ] NA[ 6.0221367e-4 ] 
 
[ S o u r c e ]  
 s-type =  1      
   proj = 12C 
   x0 = 0.0 
   y0 = 0.0 
   z0 = -17.0 
   z1 = -17.0 
   r0 =  0.1 
   dir = 1.0 
   e0 = 290 
 
[ M a t e r i a l ] 
m1   13027  -2.7  $ aluminum 
m2   14028  -2.2  $ silicon detector 
m3   1001.60c   -0.102*(1.138)  $ A-150 
     6012.60c   -0.768*(1.138) 
     7014.60c   -0.036*(1.138) 
     8016.60c   -0.059*(1.138) 
     9019.60c   -0.017*(1.138) 
    20040.60c   -0.018*(1.138) 
     
m4   1001.60c   2/3  $ Ch2 
     6012.60c   1/3 
 
 
[ S u r f a c e ]   
  1     RPP   -0.5 0.5 -0.5 0.5 -0.5 0.5 
  2     cx    10 
  3     px    10 
  4     px    -10 
  6     RPP   -5  5  -5  5  -16.5  -10.01 
  7     so    25 
  11    RPP   -0.5 0.5 -0.5 0.5 0.5 1.5   $11-15 are 1cc regions after tumor 
  12    RPP   -0.5 0.5 -0.5 0.5 1.5 2.5 
  13    RPP   -0.5 0.5 -0.5 0.5 2.5 3.5 
  14    RPP   -0.5 0.5 -0.5 0.5 3.5 4.5 
  15    RPP   -0.5 0.5 -0.5 0.5 4.5 5.5 
31 
 
  21    RPP   -0.5 0.5 0.5 1.5 -0.5 0.5  $21-25 are regions perpendicular to the beam line, aligned with 
tumor 
  22    RPP   -0.5 0.5 1.5 2.5 -0.5 0.5 
  23    RPP   -0.5 0.5 2.5 3.5 -0.5 0.5 
  24    RPP   -0.5 0.5 3.5 4.5 -0.5 0.5 
  25    RPP   -0.5 0.5 4.5 5.5 -0.5 0.5 
  31    RPP   -0.5 0.5 -0.5 0.5 -5.5 -4.5  $31 is a region 5 cmin front of the tumor 
  41    RPP   -0.5 0.5 -0.5 0.5 -9.5 -8.5  $region near the surface of the tissue 
  91    RPP   -0.5 0.5 -0.5 0.5 -16.5 -15.5 $region at the surface of the poly block 
   
 
[ C e l l ]  
  1   3   -1.0   -1    $ Tissue Sphere 
   
  11  3   -1.0  -11 
  12  3   -1.0  -12 
  13  3   -1.0  -13 
  14  3   -1.0  -14 
  15  3   -1.0  -15 
   
  21  3   -1.0  -21 
  22  3   -1.0  -22 
  23  3   -1.0  -23 
  24  3   -1.0  -24 
  25  3   -1.0  -25 
   
  31  3   -1.0  -31 
   
  41  3   -1.0  -41 
   
  91  4   -0.94 -91 
   
  2   3   -1.0   -2 +1 -3 4 11 12 13 14 15 21 22 23 24 25 31 41 $ Body Cylinder 
  4   4   -0.94  -6 91    $ poly moderator 
 
   
  5   0   -7     #1 #2 #4 #11 #12 #13 #14 #15 #21 #22 #23 #24 #25 #31 #41 #91 $ inside universe 
  6   -1   7     $ outside universe 
   
   
   
[ T - C r o s s ] 
title = tumor crossing 
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mesh = reg 
reg = 1 
 r-in   r-out  area 
  15      2      6.0 
e-type = 2 
 ne = 1 
 emin = 0.1 
 emax = 12000.0 
unit = 1 
axis = reg 
file = tumor.cross.evt 
factor = 1 
output = f-curr 
epsout = 1 
dump = -2 
  1 8  
   
[ E N D ]   
 
[ T - C r o s s ] 
title = In-Beam Fragmentation 
mesh = xyz 
 x-type =  2 
     nx =  1 
   xmin = -0.5 
   xmax =  0.5 
 y-type =  2 
     ny =  1 
   ymin = -0.5 
   ymax =  0.5 
 z-type =  2 
     nz =  200 
   zmin = -10 
   zmax =  10 
part = 2212 2112 6000012 2000004 2000003 3000006 
file = inbeam_frag 
epsout = 1 
axis = z 
unit = 1 
e-type = 2 
 ne = 1 
 emin = 0.0 
 emax = 12000.0 
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output = f-curr 
 
   
[ T - G s h o w ]  
  title = Experiment Geometry  
  mesh = xyz 
   x-type =  2 
       nx =  1 
     xmin = -0.5 
     xmax =  0.5 
   y-type =  2 
       ny =  400 
     ymin = -20 
     ymax =  20 
   z-type =  2 
       nz =  400 
     zmin = -20 
     zmax =  20 
  axis = yz 
  file = tumor.dat 
  output = 4 
epsout = 1 
 
[T - H E A T ] 
title = edep behind tumor 
mesh = reg 
reg = 1 11 12 13 14 15 
file = behind.tumor.dat 
epsout = 1 
unit = 2 
axis = reg 
 
[T - H E A T ] 
title = edep beside tumor 
mesh = reg 
reg = 1 21 22 23 24 25 
file = perpindicular.tumor.dat 
epsout = 1 
unit = 2 
axis = reg 
    
[ T - C r o s s ] 
title = tumor crossing 
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mesh = reg 
reg = 1 
 r-in   r-out  area 
  1    (2 11)   6 
e-type = 2 
 ne = 1 
 emin = 0.1 
 emax = 12000.0 
unit = 1 
axis = reg 
file = tumor.cross.evt 
factor = 1 
output = f-curr 
epsout = 1 
dump = -7 
  1 2 3 4 8 18 19 
   
 [ T - H E A T ]  
title = edep z  mesh  
mesh = xyz 
 x-type =  2 
     nx =  1 
   xmin = -0.5 
   xmax =  0.5 
 y-type =  2 
     ny =  400 
   ymin = -10 
   ymax =  10 
 z-type =  2 
     nz =  400 
   zmin = -10 
   zmax =  10 
 
 
axis = yz 
factor = 1 
part = all 
unit = 2 
file = Tissue.depth.2d.p.dat 
epsout = 1 
 
[ T - H E A T ]  
title = edep z  mesh  
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mesh = xyz 
 x-type =  2 
     nx =  1 
   xmin = -0.5 
   xmax =  0.5 
 y-type =  2 
     ny =  1 
   ymin = -0.5 
   ymax =  0.5 
 z-type =  2 
     nz =  200 
   zmin = -10 
   zmax =  10 
axis = z 
factor = 1 
part = all 
unit = 2 
file = Tissue.depth.p.dat 
epsout = 1 
 
  
 
 
 
[ T - C r o s s ] 
mesh = reg 
reg = 1 
 r-in   r-out      area 
  11     12         6 
part = all 
e-type = 2 
  ne = 1 
  emin= 0.1 
  emax = 12000 
a-type = -1 
 na= 9 
  0 10 20 30 40 50 60 70 80 90 
unit = 1 
axis = the 
file = angle.001 
title = particle angle after tumor 
output = a-curr 
epsout = 1 
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[ T - C r o s s ] 
mesh = reg 
reg = 4 
 r-in  r-out  area 
  91   4       1 
  41   2       1 
  31   2       1 
   1 (11 2)    1 
part =  all 6000012 
e-type =2  
 ne = 1 
 emin = 0.1 
 emax = 12000 
unit = 1 
axis = reg 
file = carbonleft.001 
title = depletion of carbon in beam 
output = current 
epsout = 1 
    
  
 
[ T - H e a t ]  
title = Energy Deposited in tumor 
mesh = reg 
reg = 1  
axis = eng 
file = tumor.mod.p.dat 
material = all 
e-type = 2 
 ne = 500 
 emin = 0 
 emax = 1000 
output = deposit-all 
unit = 3   
epsout = 1 
electron = 1 
 
 
     
[ T - L E T ]  
title = LET mesh  
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mesh = xyz 
 x-type =  2 
     nx =  1 
   xmin = -1 
   xmax =  1 
 y-type =  2 
     ny =  1 
   ymin = -1 
   ymax =  1 
 z-type =  2 
     nz =  500 
   zmin = -10 
   zmax =  10 
part = all 
l-type = 2 
 nl = 700 
 lmin = 0 
 lmax = 1400 
unit = 6 
axis = z 
file = Tissue.let.dat 
epsout = 1 
 
[ E n d ] 
 
[ T - H e a t ]  
title = Energy Deposited after tumor 
mesh = reg 
reg = 3  
axis = eng 
file = after.tumor.mod.p.dat 
material = all 
e-type = 2 
 ne = 700 
 emin = 0 
 emax =1400 
output = deposit-all 
unit =  3  
epsout = 1 
electron = 1 
 
[ T - C r o s s ] 
title = fragments crossing last det 
38 
 
mesh = reg 
reg = 1 
 r-in   r-out  area 
  15     14     6.45 
e-type = 2 
 ne = 1 
 emin = 0.0 
 emax = 1e9 
unit = 1 
axis = reg 
file = CR39-cross-SiBack.dat 
factor = 1 
output = f-curr 
epsout = 0 
dump = -2 
  1 8  
 
$H.102   $ muscle tissue 
  $  C.123 
  $  N.035 
  $  O.729 
  $  Na.0008 
  $  Mg.0002 
  $  P.002 
  $  S.005 
  $  K.003 
   
  [ T - 3 D s h o w ] 
    reg = all 
    output = 3 
    file = tumor.3d.dat 
    epsout = 1 
    w-dst = 50 
  shadow = 2 
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